Linganisha mbinu
Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.
| Mлениемaji wa Kawaida wa Kawaida wa Chuo Kikuu cha Saint Louis× | Kipimo cha Mattis cha Kupima Akili Kupungua (Dementia)× | |
|---|---|---|
| Nyanja | Neurosaikolojia | Neurosaikolojia |
| Familia | Process / pipeline | Process / pipeline |
| Mwaka wa asili≠ | 2006 | 1988 |
| Mwanzilishi≠ | Syed Tariq | Sandra Mattis |
| Aina≠ | Clinician-administered cognitive screening instrument | Clinician-administered comprehensive neuropsychological scale |
| Chanzo asilia≠ | Tariq, S. H., Tumosa, N., Chibnall, J. T., Perry, M. H., & Morley, J. E. (2006). Comparison of the Saint Louis University Mental Status Examination and the Mini-Mental State Examination for detecting dementia and mild neurocognitive disorder—A pilot study. American Journal of Geriatric Psychiatry, 14(11), 900-910. DOI ↗ | Mattis, S. (1988). Dementia Rating Scale (DRS). Odessa, FL: Psychological Assessment Resources. link ↗ |
| Majina mbadala≠ | SLUMS, Saint Louis Mental Status | DRS, Mattis DRS, Dementia Rating Scale |
| Zinazohusiana | 5 | 5 |
| Muhtasari≠ | The Saint Louis University Mental Status Examination (SLUMS) is a brief, clinician-administered cognitive screening instrument developed by Tariq and colleagues at Saint Louis University in 2006. It was designed as an alternative to the MMSE with improved sensitivity to mild cognitive impairment and early dementia. The SLUMS includes items assessing orientation, attention, memory, and executive function, and is particularly useful in older adult populations in primary care and geriatric settings. | The Mattis Dementia Rating Scale (DRS) is a comprehensive 36-item clinician-administered neuropsychological battery designed to assess and quantify cognitive decline in dementia. Developed by Sandra Mattis in 1988, the DRS measures five major cognitive domains—attention, initiation/perseveration, construction, conceptualization, and memory—and provides both a total score and subscale scores. The DRS is particularly valued in neurodegenerative disease research and clinical settings for its sensitivity to cognitive change over time and its utility in detecting cognitive impairment across the dementia spectrum. |
| ScholarGateSeti ya data ↗ |
|
|